Octapharma: New Consensus Recommendations on Treatment of Secondary Antibody Deficiency in Patients With Haematological Malignancies
LACHEN, Switzerland--(BUSINESS WIRE)--Feb 19, 2021-- |!| Ludington
LACHEN, Switzerland--(BUSINESS WIRE)--Feb 19, 2021-- |!| Ludington